Prime Msk Shot is under clinical development by Thomas Advanced Medical and currently in Phase II for Unspecified Cardiovascular Disorders.

APSA-02 is under clinical development by Armata Pharmaceuticals and currently in Phase II for Bacteremia. According to GlobalData, Phase II drugs for Bacteremia have a 66% phase transition success ...

PetVivo Holdings, Inc. (NASDAQ: PETVW) announced in a recent 8-K filing with the Securities and Exchange Commission (SEC) that representatives of the company are scheduled to present at upcoming ...

Correspondence to: Professor M Doherty, Academic Rheumatology, Clinical Sciences Building, University of Nottingham, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Michael.Doherty{at}Nottingham ...

Objective: To evaluate the safety of an intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) in patients with osteoarthritis (OA) of the knee. Design and setting: Non-blind ...